An enhanced ratio of CD8+ CTL to CD4+ Tregs in the tumor thus constitutes an additional potential mechanistic contribution of reduced tumor growth in mice upon blockade of the A2AR and TIM3. This evidence concerns the gene CD4 and neoplasm.